Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Aortic Valve Surgery Outcomes Reporting and Implications for Persons Who Use Drugs With Infectious Endocarditis.

Springer SA.

Clin Infect Dis. 2019 Oct 7. pii: ciz837. doi: 10.1093/cid/ciz837. [Epub ahead of print] No abstract available.

PMID:
31588502
2.

Infectious complications of addiction: A call for a new subspecialty within infectious diseases.

Serota DP, Barocas JA, Springer SA.

Clin Infect Dis. 2019 Aug 17. pii: ciz804. doi: 10.1093/cid/ciz804. [Epub ahead of print]

PMID:
31420651
3.

Pregnancy, Substance Use, and Research: How do We Protect Women while Increasing their Participation in Research?

Biondi BE, Frank C, Springer SA.

J Addict Med. 2019 Aug 8. doi: 10.1097/ADM.0000000000000565. [Epub ahead of print] No abstract available.

PMID:
31403523
4.

Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes.

Makarenko I, Pykalo I, Springer SA, Mazhnaya A, Marcus R, Filippovich S, Dvoriak S, Altice FL.

J Subst Abuse Treat. 2019 Sep;104:34-41. doi: 10.1016/j.jsat.2019.05.008. Epub 2019 May 10.

PMID:
31370983
5.

HCV reinfection is low among persons who use drugs maintained on medication treatment for Opioid Use Disorder.

Springer SA.

Clin Infect Dis. 2019 Jul 26. pii: ciz695. doi: 10.1093/cid/ciz695. [Epub ahead of print] No abstract available.

PMID:
31346595
6.

Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics.

Springer SA, Korthuis PT, Del Rio C.

Ann Intern Med. 2019 Apr 2;170(7):509. doi: 10.7326/L19-0042. No abstract available.

PMID:
30934074
7.

Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.

Fanucchi L, Springer SA, Korthuis PT.

Curr HIV/AIDS Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11904-019-00436-7. Review.

8.

Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations.

Hussong AM, Gottfredson NC, Bauer DJ, Curran PJ, Haroon M, Chandler R, Kahana SY, Delaney JAC, Altice FL, Beckwith CG, Feaster DJ, Flynn PM, Gordon MS, Knight K, Kuo I, Ouellet LJ, Quan VM, Seal DW, Springer SA.

Drug Alcohol Depend. 2019 Jan 1;194:59-68. doi: 10.1016/j.drugalcdep.2018.10.003. Epub 2018 Oct 23.

PMID:
30412898
9.
10.

Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative.

Beckwith CG, Kuo I, Fredericksen RJ, Brinkley-Rubinstein L, Cunningham WE, Springer SA, Loeliger KB, Franks J, Christopoulos K, Lorvick J, Kahana SY, Young R, Seal DW, Zawitz C, Delaney JA, Crane HM, Biggs ML.

PLoS One. 2018 May 22;13(5):e0197730. doi: 10.1371/journal.pone.0197730. eCollection 2018.

11.
12.

A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine.

Marcus R, Bojko MJ, Mazhnaya A, Makarenko I, Filippovych S, Dvoriak S, Altice FL, Springer SA.

J Subst Abuse Treat. 2018 Mar;86:86-93. doi: 10.1016/j.jsat.2018.01.003. Epub 2018 Jan 5.

13.

Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, Altice FL.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):43-53. doi: 10.1097/QAI.0000000000001634.

14.

Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision.

Mbaba M, Brown SE, Wooditch A, Kiss M, Murphy A, Kumari S, Taxman F, Altice F, Lawson WB, Springer SA.

Subst Use Misuse. 2018 Jul 29;53(9):1519-1528. doi: 10.1080/10826084.2017.1416400. Epub 2018 Jan 15.

15.

Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.

Marcus R, Makarenko I, Mazhnaya A, Zelenev A, Polonsky M, Madden L, Filippovych S, Dvoriak S, Springer SA, Altice FL.

Drug Alcohol Depend. 2017 Oct 1;179:213-219. doi: 10.1016/j.drugalcdep.2017.07.010. Epub 2017 Aug 5.

16.

The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool.

Siddiqui SS, Springer SA, Verhagen A, Sundaramurthy V, Alisson-Silva F, Jiang W, Ghosh P, Varki A.

J Biol Chem. 2017 Sep 15;292(37):15312-15320. doi: 10.1074/jbc.M117.799346. Epub 2017 Jul 26.

17.

Cohort profile: seek, test, treat and retain United States criminal justice cohort.

Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, Nance RM, Ouellet LJ, Rich JD, Sacks S, Seal D, Spaulding A, Springer SA, Taxman F, Wohl D, Young JD, Young R, Crane HM.

Subst Abuse Treat Prev Policy. 2017 May 16;12(1):24. doi: 10.1186/s13011-017-0107-4.

18.

Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40].

Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA.

J Subst Abuse Treat. 2017 Jun;77:44. doi: 10.1016/j.jsat.2017.03.008. Epub 2017 Mar 18. No abstract available.

19.
20.

Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.

Springer SA, Di Paola A, Azar MM, Barbour R, Krishnan A, Altice FL.

Drug Alcohol Depend. 2017 May 1;174:158-170. doi: 10.1016/j.drugalcdep.2017.01.026. Epub 2017 Mar 10.

21.

Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium.

Loeliger KB, Biggs ML, Young R, Seal DW, Beckwith CG, Kuo I, Gordon MS, Altice FL, Ouellet LJ, Cunningham WE, Young JD, Springer SA.

AIDS Behav. 2017 Oct;21(10):2945-2957. doi: 10.1007/s10461-017-1722-9.

22.

Reply to Liu and Jiang: Maintenance of postreproductive cognitive capacity by inclusive fitness.

Springer SA, Schwarz F, Altheide TK, Varki NM, Varki A, Gagneux P.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1591-2. doi: 10.1073/pnas.1601419113. Epub 2016 Mar 1. No abstract available.

23.

An exploratory study of therapeutic misconception among incarcerated clinical trial participants.

Christopher PP, Stein MD, Springer SA, Rich JD, Johnson JE, Lidz CW.

AJOB Empir Bioeth. 2016;7(1):24-30. Epub 2015 Jun 24.

24.

Glycomics: revealing the dynamic ecology and evolution of sugar molecules.

Springer SA, Gagneux P.

J Proteomics. 2016 Mar 1;135:90-100. doi: 10.1016/j.jprot.2015.11.022. Epub 2015 Nov 25. Review.

25.

Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Schwarz F, Springer SA, Altheide TK, Varki NM, Gagneux P, Varki A.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):74-9. doi: 10.1073/pnas.1517951112. Epub 2015 Nov 30.

26.

Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.

Springer SA, Brown SE, Di Paola A, Altice FL.

Drug Alcohol Depend. 2015 Dec 1;157:158-65. doi: 10.1016/j.drugalcdep.2015.10.023. Epub 2015 Oct 28. Erratum in: Drug Alcohol Depend. ;161:372. Altice, Frederick L [added].

27.

Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs.

Zhu C, Nigam KB, Date RC, Bush KT, Springer SA, Saier MH Jr, Wu W, Nigam SK.

PLoS One. 2015 Nov 4;10(11):e0140569. doi: 10.1371/journal.pone.0140569. eCollection 2015.

28.

The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review : Alcohol and the HIV Continuum of Care.

Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL.

Curr HIV/AIDS Rep. 2015 Dec;12(4):421-36. doi: 10.1007/s11904-015-0285-5. Review.

29.

HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study.

Vagenas P, Zelenev A, Altice FL, Di Paola A, Jordan AO, Teixeira PA, Frew PM, Spaulding AC, Springer SA.

AIDS Care. 2016;28(1):22-31. doi: 10.1080/09540121.2015.1062464. Epub 2015 Aug 14.

30.

Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.

Springer SA, Larney S, Alam-Mehrjerdi Z, Altice FL, Metzger D, Shoptaw S.

J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S155-61. doi: 10.1097/QAI.0000000000000637.

31.

Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study.

Lincoln T, Simon-Levine D, Smith J, Donenberg GR, Springer SA, Zaller N, Altice FL, Moore K, Jordan AO, Draine J, Desabrais M.

J Correct Health Care. 2015 Apr;21(2):125-39. doi: 10.1177/1078345815574566.

32.

A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community.

Di Paola A, Altice FL, Powell ML, Trestman RL, Springer SA.

Health Justice. 2014 Oct 29;2(11). doi: 10.1186/s40352-014-0011-1.

33.

Validation of a Brief Measure of Opioid Dependence: The Rapid Opioid Dependence Screen (RODS).

Wickersham JA, Azar MM, Cannon CM, Altice FL, Springer SA.

J Correct Health Care. 2015 Jan;21(1):12-26. doi: 10.1177/1078345814557513.

34.

HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.

Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL.

Lancet HIV. 2014 Nov 1;1(2):e77-e84.

35.

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA.

Contemp Clin Trials. 2014 Nov;39(2):256-68. doi: 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18.

36.

Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc.

Springer SA, Diaz SL, Gagneux P.

Immunogenetics. 2014 Nov;66(11):671-4. doi: 10.1007/s00251-014-0795-0. Epub 2014 Aug 16.

37.

Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA.

JAMA Intern Med. 2014 May;174(5):721-9. doi: 10.1001/jamainternmed.2014.601.

38.

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.

Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA.

J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12. Erratum in: J Subst Abuse Treat. 2017 Jun;77:44.

39.
40.

Partner violence and health among HIV-infected jail detainees.

Meyer JP, Wickersham JA, Fu JJ, Brown SE, Sullivan TP, Springer SA, Altice FL.

Int J Prison Health. 2013;9(3):124-41.

41.

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.

Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL.

AIDS Behav. 2013 Oct;17 Suppl 2:S118-27. doi: 10.1007/s10461-013-0506-0.

42.

Duplicate abalone egg coat proteins bind sperm lysin similarly, but evolve oppositely, consistent with molecular mimicry at fertilization.

Aagaard JE, Springer SA, Soelberg SD, Swanson WJ.

PLoS Genet. 2013;9(2):e1003287. doi: 10.1371/journal.pgen.1003287. Epub 2013 Feb 7.

43.

Glycan evolution in response to collaboration, conflict, and constraint.

Springer SA, Gagneux P.

J Biol Chem. 2013 Mar 8;288(10):6904-11. doi: 10.1074/jbc.R112.424523. Epub 2013 Jan 17. Review.

44.

Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study.

Krishnan A, Wickersham JA, Chitsaz E, Springer SA, Jordan AO, Zaller N, Altice FL.

AIDS Behav. 2013 Oct;17 Suppl 2:S171-80. doi: 10.1007/s10461-012-0362-3.

45.

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.

Springer SA, Qiu J, Saber-Tehrani AS, Altice FL.

PLoS One. 2012;7(5):e38335. doi: 10.1371/journal.pone.0038335. Epub 2012 May 31.

46.

The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.

Springer SA, Dushaj A, Azar MM.

AIDS Behav. 2012 Nov;16(8):2119-43. doi: 10.1007/s10461-012-0212-3. Review.

47.
48.

Adherence to HIV treatment and care among previously homeless jail detainees.

Chen NE, Meyer JP, Avery AK, Draine J, Flanigan TP, Lincoln T, Spaulding AC, Springer SA, Altice FL.

AIDS Behav. 2013 Oct;17(8):2654-66. doi: 10.1007/s10461-011-0080-2.

49.

High rates of depressive symptomatology among injecting drug users in Saskatoon, Canada.

Springer SA.

Evid Based Ment Health. 2012 Feb;15(1):9. doi: 10.1136/ebmh.2011.100199. Epub 2011 Nov 1. No abstract available.

PMID:
22044870
50.

Sexual selection by female immunity against paternal antigens can fix loss of function alleles.

Ghaderi D, Springer SA, Ma F, Cohen M, Secrest P, Taylor RE, Varki A, Gagneux P.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17743-8. doi: 10.1073/pnas.1102302108. Epub 2011 Oct 10.

Supplemental Content

Loading ...
Support Center